Comments on Proposed Rule: Amendments to Smaller Reporting Company Definition

Filter comments

Date Received
Date Letter Type Commenter Name
Meeting with SEC Officials Memorandum from the Office of Commissioner Kara M. Stein regarding an April 5, 2018, meeting with representatives of Biotechnology Innovation Organization
Meeting with SEC Officials Memorandum from the Office of Commissioner Robert J. Jackson regarding a March 29, 2018, meeting with representatives of BIO
Meeting with SEC Officials Memorandum from the Office of Commissioner Michael S. Piwowar regarding a February 21, 2018, meeting with representatives of Biotechnology Innovation Organization
Meeting with SEC Officials Memorandum from the Division of Corporation Finance regarding a January 16, 2018, meeting with representatives of Biotechnology Innovation Organization
Public Comment Ernst & Young LLP
Public Comment Kermit Kubitz
Public Comment Ashley W. Wittorf, Executive Director, AdvaMed Accel, Washington, District of Columbia
Public Comment Charles Crain, Director, Tax & Financial Services Policy, and E. Cartier Esham, Executive Vice President, Emerging Companies; Biotechnology Innovation Organization
Public Comment Corporate Governance Coalition for Investor Value
Public Comment Cynthia M. Fornelli, Executive Director, Center for Audit Quality, and Jeff Mahoney, General Counsel, Council of Institutional Investors
Public Comment Joan Conley, Senior Vice President and Corporate Secretary, Nasdaq, Inc.
Public Comment Kurt N. Schacht, CFA, Managing Director, Standards and Advocacy, and Linda L. Rittenhouse, Director, Capital Markets Policy; CFA Institute
Public Comment BDO USA, LLP
Public Comment Christopher Cole, Executive Vice President and Senior Regulatory Counsel, Independent Community Bankers of America
Public Comment Council of State Bioscience Associations
Public Comment Bobby Franklin, President and CEO, National Venture Capital Association
Public Comment C. R. Cloutier, President/Chief Executive Officer, MidSouth Bancorp, Inc.
Public Comment Gerald S. Silberstein, PhD, CPA, MBA, CMA, Chair, Small Business Financial and Regulatory Affairs Committee, Institute of Management Accountants
Public Comment Acorda Therapeutics, Inc., et al.
Public Comment Deloitte & Touche LLP
Public Comment William D. Waddill, Senior Vice President and Chief Financial Officer, Calithera Biosciences, Inc.
Public Comment Greg McKee, CEO, CONNECT, San Diego, California
Public Comment Timothy Benjamin, CFO, Seneca Foods Corporation
Public Comment Thomas Farley, President, New York Stock Exchange
Public Comment Paul W. Zeller, Esq.
Public Comment Jon Faulkner, CFO, The Dixie Group, Inc.
Public Comment Jacob Ma-Weaver, Managing Member, Cable Car Capital LLC, San Francisco, California

Last Reviewed or Updated: Dec. 18, 2025

File Number
S7-12-16
Release Number
33-10107
Related Materials
How to submit comments